{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:30:30Z","timestamp":1791145830106,"version":"4.1.0"},"reference-count":9,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,1,1]]},"DOI":"10.1176\/appi.ajp.159.1.145","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:20:39Z","timestamp":1034360439000},"page":"145-147","source":"Crossref","is-referenced-by-count":102,"title":["GABA<sub>A<\/sub> Receptor-Modulating Neuroactive Steroid Composition in Patients With Panic Disorder Before and During Paroxetine Treatment"],"prefix":"10.1176","volume":"159","author":[{"given":"Andreas","family":"Str\u00f6hle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"di Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yassouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Holsboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1591BIHEDAJI","doi-asserted-by":"crossref","unstructured":"Paul SM, Purdy RH: Neuroactive steroids. FASEB J 1992; 6:2311-2322","DOI":"10.1096\/fasebj.6.6.1347506"},{"key":"R1591BIHCICHD","doi-asserted-by":"crossref","unstructured":"Rupprecht R, Holsboer F: Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 1999; 22:410-416","DOI":"10.1016\/S0166-2236(99)01399-5"},{"key":"R1591BIHDFIFI","unstructured":"Str\u00f6hle A, Romeo E, di Michele F, Pasini A, Holsboer F, Rupprecht R: Panic attacks shift GABAA receptor modulatory neuroactive steroid composition (abstract). Pharmacopsychiatry 2001; 34:203"},{"key":"R1591BIHIGGBH","doi-asserted-by":"crossref","unstructured":"Bandelow B: Assessing the efficacy of treatments for panic disorder and agoraphobia, II: the Panic and Agoraphobia Scale. Int Clin Psychopharmacol 1995; 10:73-81","DOI":"10.1097\/00004850-199506000-00003"},{"key":"R1591BIHJBCBI","doi-asserted-by":"crossref","unstructured":"Romeo E, Str\u00f6hle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R: Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998; 155:910-913","DOI":"10.1176\/ajp.155.7.910"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998; 95:3239-3244","DOI":"10.1073\/pnas.95.6.3239"},{"key":"R1591BIHIIHBJ","doi-asserted-by":"crossref","unstructured":"Str\u00f6hle A, Pasini A, Romeo E, Hermann B, Spalletta G, di Michele F, Holsboer F, Rupprecht R: Fluoxetine decreases concentrations of 3\u03b1,5\u03b1-tetrahydrodeoxycorticosterone (THDOC) in major depression. J Psychiatr Res 2000; 34:183-186","DOI":"10.1016\/S0022-3956(00)00006-6"},{"key":"R1591BIHIFACE","doi-asserted-by":"crossref","unstructured":"Griffin LD, Mellon SH: Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 1999; 96:13512-13517","DOI":"10.1073\/pnas.96.23.13512"},{"key":"R1591BIHFFBIB","doi-asserted-by":"crossref","unstructured":"Roy-Byrne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D: Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 1990; 47:534-538","DOI":"10.1001\/archpsyc.1990.01810180034006"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.1.145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T14:15:25Z","timestamp":1722176125000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.1.145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["10.1176\/appi.ajp.159.1.145"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.1.145","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]}}}